BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 32276640)

  • 1. Moving beyond the mousetrap: current and emerging humanized mouse and rat models for investigating prevention and cure strategies against HIV infection and associated pathologies.
    Agarwal Y; Beatty C; Biradar S; Castronova I; Ho S; Melody K; Bility MT
    Retrovirology; 2020 Apr; 17(1):8. PubMed ID: 32276640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human immunodeficiency virus infection induces lymphoid fibrosis in the BM-liver-thymus-spleen humanized mouse model.
    Samal J; Kelly S; Na-Shatal A; Elhakiem A; Das A; Ding M; Sanyal A; Gupta P; Melody K; Roland B; Ahmed W; Zakir A; Bility M
    JCI Insight; 2018 Sep; 3(18):. PubMed ID: 30232273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Humanized Mice Engrafted With Human HSC Only or HSC and Thymus Support Comparable HIV-1 Replication, Immunopathology, and Responses to ART and Immune Therapy.
    Cheng L; Ma J; Li G; Su L
    Front Immunol; 2018; 9():817. PubMed ID: 29725337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The utility of the new generation of humanized mice to study HIV-1 infection: transmission, prevention, pathogenesis, and treatment.
    Berges BK; Rowan MR
    Retrovirology; 2011 Aug; 8():65. PubMed ID: 21835012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of caspase pathways limits CD4
    Holloway AJ; Saito TB; Naqvi KF; Huante MB; Fan X; Lisinicchia JG; Gelman BB; Endsley JJ; Endsley MA
    Retrovirology; 2024 May; 21(1):8. PubMed ID: 38693565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV Replication and Latency in a Humanized NSG Mouse Model during Suppressive Oral Combinational Antiretroviral Therapy.
    Satheesan S; Li H; Burnett JC; Takahashi M; Li S; Wu SX; Synold TW; Rossi JJ; Zhou J
    J Virol; 2018 Apr; 92(7):. PubMed ID: 29343582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benefits and limitations of humanized mice in HIV persistence studies.
    Marsden MD
    Retrovirology; 2020 Apr; 17(1):7. PubMed ID: 32252791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Humanized mouse models to study pathophysiology and treatment of HIV infection.
    Masse-Ranson G; Mouquet H; Di Santo JP
    Curr Opin HIV AIDS; 2018 Mar; 13(2):143-151. PubMed ID: 29194124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humanized mouse models of HIV-1 latency.
    Duyne RV; Narayanan A; K-Hall K; Saifuddin M; Shultz L; Kashanchi F
    Curr HIV Res; 2011 Dec; 9(8):595-605. PubMed ID: 22211664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perspectives on Non-BLT Humanized Mouse Models for Studying HIV Pathogenesis and Therapy.
    Terahara K; Iwabuchi R; Tsunetsugu-Yokota Y
    Viruses; 2021 Apr; 13(5):. PubMed ID: 33924786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human Immune System Mice for the Study of Human Immunodeficiency Virus-Type 1 Infection of the Central Nervous System.
    Evering TH; Tsuji M
    Front Immunol; 2018; 9():649. PubMed ID: 29670623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Humanized Mouse Models for Human Immunodeficiency Virus Infection.
    Marsden MD; Zack JA
    Annu Rev Virol; 2017 Sep; 4(1):393-412. PubMed ID: 28746819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune reconstitution of the female reproductive tract of humanized BLT mice and their susceptibility to human immunodeficiency virus infection.
    Olesen R; Wahl A; Denton PW; Garcia JV
    J Reprod Immunol; 2011 Mar; 88(2):195-203. PubMed ID: 21256601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BLT humanized mice as a small animal model of HIV infection.
    Karpel ME; Boutwell CL; Allen TM
    Curr Opin Virol; 2015 Aug; 13():75-80. PubMed ID: 26083316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiretroviral pre-exposure prophylaxis prevents vaginal transmission of HIV-1 in humanized BLT mice.
    Denton PW; Estes JD; Sun Z; Othieno FA; Wei BL; Wege AK; Powell DA; Payne D; Haase AT; Garcia JV
    PLoS Med; 2008 Jan; 5(1):e16. PubMed ID: 18198941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-Throughput Humanized Mouse Models for Evaluation of HIV-1 Therapeutics and Pathogenesis.
    Thomas T; Seay K; Zheng JH; Zhang C; Ochsenbauer C; Kappes JC; Goldstein H
    Methods Mol Biol; 2016; 1354():221-35. PubMed ID: 26714715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cat and Mouse: HIV Transcription in Latency, Immune Evasion and Cure/Remission Strategies.
    Delannoy A; Poirier M; Bell B
    Viruses; 2019 Mar; 11(3):. PubMed ID: 30889861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular HIV Reservoirs and Viral Rebound from the Lymphoid Compartments of 4'-Ethynyl-2-Fluoro-2'-Deoxyadenosine (EFdA)-Suppressed Humanized Mice.
    Maidji E; Moreno ME; Rivera JM; Joshi P; Galkina SA; Kosikova G; Somsouk M; Stoddart CA
    Viruses; 2019 Mar; 11(3):. PubMed ID: 30871222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of Humanized Mouse Models for Studying HIV-1 Infection, Pathogenesis and Persistence.
    Weichseldorfer M; Heredia A; Reitz M; Bryant JL; Latinovic OS
    J AIDS HIV Treat; 2020; 2(1):23-29. PubMed ID: 32457941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Humanized Mouse Model of HIV-1 Latency with Enrichment of Latent Virus in PD-1
    Llewellyn GN; Seclén E; Wietgrefe S; Liu S; Chateau M; Pei H; Perkey K; Marsden MD; Hinkley SJ; Paschon DE; Holmes MC; Zack JA; Louie SG; Haase AT; Cannon PM
    J Virol; 2019 May; 93(10):. PubMed ID: 30842333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.